iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States.
$0.73-4.00%
报价 2026-11-13
市值
$51.6M
EV
$-15.5M
PE (TTM)
–
预期 PE (FY2027)
–
52 周区间距高点 -76.2%
$0.71$3.07
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| IBIOiBio, Inc. | $51.6M | -4.0% | -50.0% | -160% | – | – | – | |
| ANTXAN2 Therapeutics, Inc. | $172.6M | +2.5% | +119.0% | 0% | – | – | – | |
| RLYBRallybio Corporation | $84.6M | +0.4% | -85.7% | 99.7% | – | – | 2.8x | |
| BOLDBoundless Bio, Inc. | $59M | +1.6% | – | 0% | – | – | – | |
| PLURPluri Inc. | $11.3M | -3.7% | – | 44.6% | – | – | – | |
| INTSIntensity Therapeutics, Inc. | $8.3M | -0.6% | – | 0% | – | – | – | |
| XCURExicure, Inc. | $7.1M | +1.9% | – | 0% | – | – | – | |
| CVKDCadrenal Therapeutics, Inc. Common Stock | $5.4M | +4.1% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +16.6% | 0% | – | – | 2.8x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。